<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?>
<article xml:lang="KO" article-type="case-report">

<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Tuberc Respir Dis</journal-id>
<journal-id journal-id-type="publisher-id">TRD</journal-id>
<journal-title>Tuberculosis and Respiratory Diseases</journal-title>
<issn pub-type="ppub">1738-3536</issn>
<issn pub-type="epub">2005-6184</issn>
<publisher>
<publisher-name>The Korean Academy of Tuberculosis and Respiratory Diseases</publisher-name>
</publisher>
</journal-meta>

<article-meta>
<article-id pub-id-type="doi">10.4046/trd.2007.62.2.125</article-id>
<article-categories>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Case of Subungal Abscess and Onycholysis Induced by Docetaxel</article-title>
</title-group>

<contrib-group>

<contrib contrib-type="author">
<name>
<surname>Jung</surname>
<given-names>Han Young</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Chang Youl</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hyung Jung</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Ahn</surname>
<given-names>Chul Min</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Yoon Soo</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>

</contrib-group>

<aff id="A1"><label>1</label>Department of Internal Medicine, The Yonsei University College of Medicine, Seoul, Korea.</aff>
<aff id="A2"><label>2</label>Institute of Chest Diseases, The Yonsei University College of Medicine, Seoul, Korea.</aff>

<author-notes>
<corresp>Address for correspondence: Yoon Soo Chang, M.D. Department of Internal Medicine, 8<sup>th</sup> Floor Annex Building Yongdong Severance Hospital, 146-92 Dogok-dong, Kangnam-gu, Seoul 135-270, Korea. Tel: 02-2019-3309, Fax: 02-3463-3882, <email>yschang@yumc.yonsei.ac.kr</email></corresp>
</author-notes>

<pub-date pub-type="ppub">
<month>02</month>
<year>2007</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>02</month>
<year>2007</year>
</pub-date>
<volume>62</volume>
<issue>2</issue>
<fpage>125</fpage>
<lpage>128</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>12</month>
<year>2006</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>02</month>
<year>2007</year>
</date>
</history>

<permissions>
<copyright-statement>Copyright &#x00A9; 2007 The Korean Academy of Tuberculosis and Respiratory Diseases</copyright-statement>
<copyright-year>2007</copyright-year>
</permissions>

<abstract>
<p>Docetaxel is a taxoid antineoplastic drug, which is widely used to treat locally advanced or metastatic non-small cell lung cancer (NSCLC). Among the adverse dermatological reactions, nail disorders such as bending, onycholysis, hypo- or hyperpigmentation are rare. We report a case of a 62-year-old male with advanced NSCLC (cT<sub>4</sub>N<sub>3</sub>M<sub>1</sub>, stage IV), who developed purulent discharge and onycholysis in the nail of all his fingers and the left great toe after five courses of anti-neoplastic chemotherapy, which included docetaxel (cumulative dose: 370 mg/m<sup>2</sup>, 590 mg). Seven days after the final session of chemotherapy, the patient had become aware of discoloration and swelling of the nail beds with out pain. Three days later, greenish-yellow purulent discharge oozed out from the involved nails. Microbiologic studies revealed <italic>Pseudomonas aeruginosa</italic>. Intravenous and topical antibiotics (mupirocin) were applied. After 2 weeks, regrown nails were observed and the onycholysis had improved.</p>
</abstract>

<kwd-group>
<kwd>Docetaxel</kwd>
<kwd>Onycholysis</kwd>
<kwd>Subungal abscess</kwd>
</kwd-group>

</article-meta>
</front>

<back>

<ref-list>
  <ref id="B1">
    <label>1</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Miller</surname>
          <given-names>VA</given-names>
        </name>
        <name>
          <surname>Krug</surname>
          <given-names>LM</given-names>
        </name>
        <name>
          <surname>Ng</surname>
          <given-names>KK</given-names>
        </name>
        <name>
          <surname>Pizzo</surname>
          <given-names>B</given-names>
        </name>
        <name>
          <surname>Perez</surname>
          <given-names>W</given-names>
        </name>
        <name>
          <surname>Heelan</surname>
          <given-names>RT</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer</article-title>
      <source>J Clin Oncol</source>
      <year>2000</year>
      <volume>18</volume>
      <fpage>1346</fpage>
      <lpage>1350</lpage>
    </nlm-citation>
  </ref>

  <ref id="B2">
    <label>2</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Janinis</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Papadakou</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Panagos</surname>
          <given-names>G</given-names>
        </name>
        <name>
          <surname>Panousaki</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Georgoulias</surname>
          <given-names>V</given-names>
        </name>
        <name>
          <surname>Hatzidaki</surname>
          <given-names>D</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer</article-title>
      <source>Am J Clin Oncol</source>
      <year>2001</year>
      <volume>24</volume>
      <fpage>227</fpage>
      <lpage>231</lpage>
    </nlm-citation>
  </ref>

  <ref id="B3">
    <label>3</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Tinio</surname>
          <given-names>P</given-names>
        </name>
        <name>
          <surname>Bershad</surname>
          <given-names>S</given-names>
        </name>
        <name>
          <surname>Levitt</surname>
          <given-names>JO</given-names>
        </name>
      </person-group>
      <article-title>Docetaxel-induced onycholysis</article-title>
      <source>J Am Acad Dermatol</source>
      <year>2005</year>
      <volume>52</volume>
      <fpage>350</fpage>
      <lpage>351</lpage>
    </nlm-citation>
  </ref>

  <ref id="B4">
    <label>4</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Obermair</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Binder</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Barrada</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Bancher-Todesca</surname>
          <given-names>D</given-names>
        </name>
        <name>
          <surname>Asseryanis</surname>
          <given-names>E</given-names>
        </name>
        <name>
          <surname>Kubista</surname>
          <given-names>E</given-names>
        </name>
      </person-group>
      <article-title>Onycholysis in patients treated with docetaxel</article-title>
      <source>Ann Oncol</source>
      <year>1998</year>
      <volume>9</volume>
      <fpage>230</fpage>
      <lpage>231</lpage>
    </nlm-citation>
  </ref>

  <ref id="B5">
    <label>5</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Almagro</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Pozo</surname>
          <given-names>JD</given-names>
        </name>
        <name>
          <surname>Garcia</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Vasquez</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Fonseca</surname>
          <given-names>E</given-names>
        </name>
      </person-group>
      <article-title>Nail alterations secondary to paclitaxel therapy</article-title>
      <source>Eur J Dermatol</source>
      <year>2000</year>
      <volume>10</volume>
      <fpage>146</fpage>
      <lpage>147</lpage>
    </nlm-citation>
  </ref>

  <ref id="B6">
    <label>6</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Moisidis</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Mobus</surname>
          <given-names>V</given-names>
        </name>
      </person-group>
      <article-title>Erythema multiforme major following docetaxel</article-title>
      <source>Arch Gynecol Obstet</source>
      <year>2005</year>
      <volume>271</volume>
      <fpage>267</fpage>
      <lpage>269</lpage>
    </nlm-citation>
  </ref>

  <ref id="B7">
    <label>7</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Minisini</surname>
          <given-names>AM</given-names>
        </name>
        <name>
          <surname>Tosti</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Sobrero</surname>
          <given-names>AF</given-names>
        </name>
        <name>
          <surname>Mansutti</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Piraccini</surname>
          <given-names>BM</given-names>
        </name>
        <name>
          <surname>Sacco</surname>
          <given-names>C</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Taxane-induced nail changes: incidence, clinical presentation and outcome</article-title>
      <source>Ann Oncol</source>
      <year>2003</year>
      <volume>14</volume>
      <fpage>333</fpage>
      <lpage>337</lpage>
    </nlm-citation>
  </ref>

  <ref id="B8">
    <label>8</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Correia</surname>
          <given-names>O</given-names>
        </name>
        <name>
          <surname>Azevedo</surname>
          <given-names>C</given-names>
        </name>
        <name>
          <surname>Pinto Ferreira</surname>
          <given-names>E</given-names>
        </name>
        <name>
          <surname>Braga Cruz</surname>
          <given-names>F</given-names>
        </name>
        <name>
          <surname>Polonia</surname>
          <given-names>J</given-names>
        </name>
      </person-group>
      <article-title>Nail changes secondary to docetaxel (Taxotere)</article-title>
      <source>Dermatology</source>
      <year>1999</year>
      <volume>198</volume>
      <fpage>288</fpage>
      <lpage>290</lpage>
    </nlm-citation>
  </ref>

  <ref id="B9">
    <label>9</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Vanhooteghem</surname>
          <given-names>O</given-names>
        </name>
        <name>
          <surname>Andre</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Vindevoghel</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Vandenbossche</surname>
          <given-names>L</given-names>
        </name>
        <name>
          <surname>Vandeveire</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Song</surname>
          <given-names>M</given-names>
        </name>
      </person-group>
      <article-title>Docetaxel-induced subungal hemorrhage</article-title>
      <source>Dermatology</source>
      <year>1997</year>
      <volume>194</volume>
      <fpage>419</fpage>
      <lpage>420</lpage>
    </nlm-citation>
  </ref>

  <ref id="B10">
    <label>10</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Lee</surname>
          <given-names>MS</given-names>
        </name>
        <name>
          <surname>Kim</surname>
          <given-names>HO</given-names>
        </name>
        <name>
          <surname>Park</surname>
          <given-names>YM</given-names>
        </name>
      </person-group>
      <article-title>A case of subungal abscess and onycholysis related to docetaxel</article-title>
      <source>Korean J Dermatol</source>
      <year>2003</year>
      <volume>41</volume>
      <fpage>1393</fpage>
      <lpage>1395</lpage>
    </nlm-citation>
  </ref>

  <ref id="B11">
    <label>11</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Nicolopoulos</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Howard</surname>
          <given-names>A</given-names>
        </name>
      </person-group>
      <article-title>Docetaxel-induced nail dystrophy</article-title>
      <source>Australas J Dermatol</source>
      <year>2002</year>
      <volume>43</volume>
      <fpage>293</fpage>
      <lpage>296</lpage>
    </nlm-citation>
  </ref>

  <ref id="B12">
    <label>12</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Wasner</surname>
          <given-names>G</given-names>
        </name>
        <name>
          <surname>Hilpert</surname>
          <given-names>F</given-names>
        </name>
        <name>
          <surname>Schattschneider</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Binder</surname>
          <given-names>A</given-names>
        </name>
        <name>
          <surname>Pfisterer</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Baron</surname>
          <given-names>R</given-names>
        </name>
      </person-group>
      <article-title>Docetaxel-induced nail changes: a neurogenic mechanism: a case report</article-title>
      <source>J Neurooncol</source>
      <year>2002</year>
      <volume>58</volume>
      <fpage>167</fpage>
      <lpage>174</lpage>
    </nlm-citation>
  </ref>

  <ref id="B13">
    <label>13</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Jones</surname>
          <given-names>R</given-names>
        </name>
        <name>
          <surname>Ryan</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Friedlander</surname>
          <given-names>M</given-names>
        </name>
      </person-group>
      <article-title>Carboplatin hypersensitivity reactions: retreatment with cisplatin desensitisation</article-title>
      <source>Gynecol Oncol</source>
      <year>2003</year>
      <volume>89</volume>
      <fpage>112</fpage>
      <lpage>115</lpage>
    </nlm-citation>
  </ref>

  <ref id="B14">
    <label>14</label>
    <nlm-citation citation-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Scotte</surname>
          <given-names>F</given-names>
        </name>
        <name>
          <surname>Tourani</surname>
          <given-names>JM</given-names>
        </name>
        <name>
          <surname>Banu</surname>
          <given-names>E</given-names>
        </name>
        <name>
          <surname>Peyromaure</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Levy</surname>
          <given-names>E</given-names>
        </name>
        <name>
          <surname>Marsan</surname>
          <given-names>S</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand</article-title>
      <source>J Clin Oncol</source>
      <year>2005</year>
      <volume>23</volume>
      <fpage>4424</fpage>
      <lpage>4429</lpage>
    </nlm-citation>
  </ref>
</ref-list>

</back>

<floats-wrap>

<fig position="float" id="F1">
<label>Figure 1</label>
<caption>
  <p>Computed tomography shows mass lesion in the lower lobe of left lung</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="trd-62-125-g001" alt-version="no"></graphic>
</fig>

<fig position="float" id="F2">
<label>Figure 2</label>
<caption>
  <p>After 5<sup>th</sup> chemotherapy, computed tomography shows marked resolution of primary tumor in the ekf</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="trd-62-125-g002" alt-version="no"></graphic>
</fig>

<fig position="float" id="F3">
<label>Figure 3</label>
<caption>
  <p>At initial admission, all finger nails showed subungal abscess and onycholysis induced by docetaxel.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="trd-62-125-g003" alt-version="no"></graphic>
</fig>

<fig position="float" id="F4">
<label>Figure 4</label>
<caption>
  <p>All finger nails showed improvement after 14-days antibiotic treatment.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="trd-62-125-g004" alt-version="no"></graphic>
</fig>

</floats-wrap>

</article>